
(Reuters) – Approvals for a potential COVID-19 vaccine later this year might threaten the recent surge in speculative financial investment in big U.S. innovation companies and pull investors back towards more … [+940 chars]
(Reuters) – Approvals for a potential COVID-19 vaccine later this year might threaten the recent surge in speculative financial investment in big U.S. innovation companies and pull investors back towards more … [+940 chars]